.svg){kind=small}
Aug-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Remedi has shown varied performance across different product categories and states. In Illinois, Remedi has maintained a stable presence in the Capsules category, holding a consistent rank of 6th place in both May and June 2025. However, the absence of rankings in July and August indicates that they fell out of the top 30, which could be a point of concern. Conversely, in the Tincture & Sublingual category, Remedi has demonstrated resilience, maintaining a strong position, even though there was a slight dip in July. The brand's performance in Concentrates in Illinois has been stable with a steady rank of 21, despite fluctuations in sales figures, suggesting a solid foothold in this category.
In Massachusetts, the performance of Remedi in the Concentrates category has been more volatile. The brand experienced a significant drop in rank from 34th in May to 45th in June, but it rebounded to 21st place by August. This recovery in ranking is coupled with an increase in sales during the same period, indicating a potential strategic shift or market response that favored the brand. However, the initial drop out of the top 30 in June could suggest challenges in maintaining consistent market traction. The variability in performance across states and categories highlights the dynamic nature of the cannabis market and the competitive landscape Remedi navigates.
Competitive Landscape
In the Illinois concentrates market, Remedi has maintained a consistent rank at 21st place from June to August 2025, showing a stable presence despite the competitive landscape. Notably, Legacy Cannabis (IL) has seen fluctuations, with a drop from 15th in June to 19th in August, indicating potential volatility that Remedi has managed to avoid. Meanwhile, nuEra experienced a significant jump to 19th in July before falling to 23rd in August, suggesting a temporary surge that did not sustain. Redemption Botanicals has been a close competitor, slightly outperforming Remedi by ranking 20th in both July and August. Despite these dynamics, Remedi's sales have shown a positive trend, peaking in July, which could indicate growing consumer loyalty and effective marketing strategies. This stable rank and upward sales trajectory position Remedi as a resilient player in the Illinois concentrates market, capable of withstanding competitive pressures from brands like Amber and others.
Notable Products
In August 2025, the top-performing product for Remedi was the Indica Relief RSO Syringe (0.5g) in the Concentrates category, maintaining its top rank from May and June after a slight dip in July. This product achieved sales of 1996 units, showcasing its consistent popularity. The Indica Rest RSO Dropper (0.5g) remained strong in the second position, swapping ranks with the Indica Relief RSO Syringe between July and August. The Indica Rest RSO Syringe (0.5g) climbed to third place from fourth in July, indicating a positive trend in its performance. The CBD/THC 1:5 Rest Tincture held steady in fourth place, while the CBD/THC 1:1 Relief Tincture re-entered the rankings at fifth place after not being ranked in July.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
